Press Releases

SCHAUMBURG, Ill., May 28, 2024 /PRNewswire/ -- Sagent Pharmaceuticals today announced the voluntary nationwide recall of two lots of Docetaxel Injection, USP (80 mg per 8 mL multi-dose vials and 160 mg per 16 mL multi-dose vials). The product was distributed by Sagent Pharmaceuticals. Sagent has initiated this voluntary recall of Docetaxel Injection, USP to the User Level as the result of a customer complaint due to potential presence of particulate matter from the... (continue reading...)

VANCOUVER, BC, May 28, 2024 /PRNewswire/ - NexGen Energy Ltd. ("NexGen" or the "Company") (TSX: NXE) (NYSE: NXE) (ASX: NXG) is pleased to announce that it has closed its previously announced purchase (the "Purchase") of 2,702,410 pounds natural uranium concentrate ("U3O8") for an aggregate purchase price of US$250 million, which was satisfied through the issuance of US$250 million aggregate principal amount of five year, 9.0% per annum (payable 2/3 cash and 1/3... (continue reading...)

NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intel Corporation (NASDAQ: INTC) between January 25, 2024 and April 25, 2024, both dates inclusive (the “Class Period”), of the important July 2, 2024 lead plaintiff deadline.

SO WHAT: If you purchased Intel securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs... (continue reading...)

• Issue was over-subscribed by 5x with demand reaching US$ 3.2 billion.
• The funds will be used to prepay the senior notes due 2025 and other debt, improving the Company's maturity profile.

SANTIAGO, Chile--(BUSINESS WIRE)-- Cencosud S.A. placed a US$ 650 million 7-year international bond at a rate of 5.95%, with initial demand exceeding US$ 3.2 billion. The operation received 230 orders and funds will be used for prepaying an international bond and the debt... (continue reading...)

GREENFIELD, IN / ACCESSWIRE / May 28, 2024 / Elanco

• Food and Drug Administration confirms Bovaer meets safety and efficacy requirements
• Elanco expects product launch and added carbon credit value to producers beginning in the third quarter
• Elanco announces agreement with dsm-firmenich to expand distribution of Bovaer across North America, adding both the Canada and Mexico markets

Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug... (continue reading...)